Literature DB >> 30663025

Diagnostic performance of magnetic resonance to assess treatment response after neoadjuvant therapy in patients with locally advanced rectal cancer.

Sergio Carlos Nahas1,2, Caio Sergio Rizkallah Nahas1,2, Gerson Montoya Cama1, Rodrigo Lautert de Azambuja3,4, Natally Horvat5,6, Carlos Frederico Sparapan Marques1,2, Marcos Roberto Menezes3,4, Ulysses Ribeiro Junior1, Ivan Cecconello1,2.   

Abstract

PURPOSE: Our study aimed to evaluate the diagnostic performance of rectal magnetic resonance imaging (MRI) for local restaging in patients with non-metastatic locally advanced rectal cancer (LARC) after neoadjuvant chemoradiotherapy (CRT) using surgical histopathology of total mesorectal excision as the reference standard.
METHODS: Ninety-five patients with LARC who underwent rectal MRI after CRT between January 2014 and December 2016 were included. Accuracy, sensitivity, specificity, positive, and negative predictive value for local staging regarding T-stage, N-stage, circumferential resection margin, and MRI tumor regression grade (ymriTRG) were calculated, and inter-test agreements were assessed.
RESULTS: 22/95 (23.2%) patients had radiological complete response (rCR), whereas 20/95 (21.1%) had pathological complete response (pCR). Among the patients with pCR, 11/20 (55%) had rCR. Fair agreement was demonstrated between ymriTRG and pathological TRG (ypTRG) (κ = 0.255). The sensitivity and specificity for detection of pCR were 61.1% (95% CI 35.7-82.7) and 89.6% (95% CI 80.6-95.4). For the detection of ypTRG grades 1 and 2, the corresponding values were 67.2% (95% CI 54.3-78.4) and 51.6 (95% CI 33.1-69.8). The accuracy of ymriTRG was 24.2% (95% CI 15.6-32.8). Inter-test agreement in TRG between MRI and pathology was overall fair (κ = 0.255) and slight (κ = 0.179), if TRG 1 + 2.
CONCLUSION: Qualitative assessment on MRI for diagnosing pCR showed moderate sensitivity and high specificity, whereas the diagnosis of TRG had moderate sensitivity and low specificity with slight to fair inter-test agreement when compared with pathological specimens.

Entities:  

Keywords:  Magnetic resonance; Neoadjuvant therapy; Rectal neoplasms

Year:  2019        PMID: 30663025     DOI: 10.1007/s00261-019-01894-8

Source DB:  PubMed          Journal:  Abdom Radiol (NY)


  7 in total

Review 1.  MRI for Rectal Cancer: Staging, mrCRM, EMVI, Lymph Node Staging and Post-Treatment Response.

Authors:  David D B Bates; Maria El Homsi; Kevin J Chang; Neeraj Lalwani; Natally Horvat; Shannon P Sheedy
Journal:  Clin Colorectal Cancer       Date:  2021-11-14       Impact factor: 4.481

Review 2.  Lymph Nodes Evaluation in Rectal Cancer: Where Do We Stand and Future Perspective.

Authors:  Alessandra Borgheresi; Federica De Muzio; Andrea Agostini; Letizia Ottaviani; Alessandra Bruno; Vincenza Granata; Roberta Fusco; Ginevra Danti; Federica Flammia; Roberta Grassi; Francesca Grassi; Federico Bruno; Pierpaolo Palumbo; Antonio Barile; Vittorio Miele; Andrea Giovagnoni
Journal:  J Clin Med       Date:  2022-05-05       Impact factor: 4.964

Review 3.  The importance of MRI for rectal cancer evaluation.

Authors:  Maria Clara Fernandes; Marc J Gollub; Gina Brown
Journal:  Surg Oncol       Date:  2022-03-18       Impact factor: 2.388

4.  MRI Assessment of Complete Response to Preoperative Chemoradiation Therapy for Rectal Cancer: 2020 Guide for Practice from the Korean Society of Abdominal Radiology.

Authors:  Seong Ho Park; Seung Hyun Cho; Sang Hyun Choi; Jong Keon Jang; Min Ju Kim; Seung Ho Kim; Joon Seok Lim; Sung Kyoung Moon; Ji Hoon Park; Nieun Seo
Journal:  Korean J Radiol       Date:  2020-07       Impact factor: 3.500

5.  MRI Evaluation of Complete and Near-Complete Response after Neoadjuvant Therapy in Patients with Locally Advanced Rectal Cancer.

Authors:  Anca-Raluca Popita; Cosmin Lisencu; Adriana Rusu; Cristian Popita; Calin Cainap; Alexandru Irimie; Liliana Resiga; Alina Munteanu; Zsolt Fekete; Radu Badea
Journal:  Diagnostics (Basel)       Date:  2022-04-07

6.  Diagnostic Value of Multimodal Magnetic Resonance Imaging in Discriminating Between Metastatic and Non-Metastatic Pelvic Lymph Nodes in Cervical Cancer.

Authors:  Jian Xu; Yingli Ma; Haibing Mei; Qimin Wang
Journal:  Int J Gen Med       Date:  2022-07-22

7.  Magnetic Resonance Imaging Evaluation of the Accuracy of Various Lymph Node Staging Criteria in Rectal Cancer: A Systematic Review and Meta-Analysis.

Authors:  Zixuan Zhuang; Yang Zhang; Mingtian Wei; Xuyang Yang; Ziqiang Wang
Journal:  Front Oncol       Date:  2021-07-13       Impact factor: 6.244

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.